Mark Turco, MD
Mark Turco, MD
CEO
Cardiac Implants
Dr. Mark Turco, a healthcare and business executive with 30+ years of academic, private, and public sector expertise. Dr. Turco was the Director, Center for Cardiac and Vascular Research at Washington Adventist Hospital before transitioning to the medical device industry working in operating roles at two-large-cap companies. Dr. Turco was instrumental in helping to build out Covidien’s vascular platform, which was subsequently a key component of Medtronic’s $49B acquisition of Covidien later returning to the academic sector leading innovation efforts at the University of Pennsylvania, Philadelphia, PA as their Chief Innovation officer. Dr. Turco was instrumental in the develop at UPenn of a large medical device center that connected medicine and engineering helping to facilitate the two schools producing numerous spin out companies and building important industry and academic collaborations. Currently, Dr. Turco is the President and CEO of Cardiac Implants LLC, a clinical stage medical device start-up with a novel treatment for Tricuspid valvular disease.